Deepak Govil to Treatment Outcome
This is a "connection" page, showing publications Deepak Govil has written about Treatment Outcome.
Connection Strength
0.015
-
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021 05; 9(5):511-521.
Score: 0.008
-
Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single-center experience. Clin Transplant. 2017 03; 31(3).
Score: 0.006